Outlook Therapeutics Inc Stock Technical Analysis
| OTLK Stock | USD 0.44 0.02 4.76% |
As of the 5th of March, OUTLOOK THERAPEUTICS holds the Coefficient Of Variation of (689.62), market risk adjusted performance of 2.4, and Risk Adjusted Performance of (0.1). In connection with fundamental indicators, the technical analysis model allows you to check available technical drivers of OUTLOOK THERAPEUTICS, as well as the relationship between them.
OUTLOOK THERAPEUTICS Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as OUTLOOK, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to OUTLOOKOUTLOOK THERAPEUTICS's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.OUTLOOK THERAPEUTICS Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 5.38 | Strong Buy | 6 | Odds |
Most OUTLOOK analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand OUTLOOK stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of OUTLOOK THERAPEUTICS INC, talking to its executives and customers, or listening to OUTLOOK conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OUTLOOK THERAPEUTICS. Anticipated expansion of OUTLOOK directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive OUTLOOK THERAPEUTICS assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (2.89) | Revenue Per Share | Quarterly Revenue Growth 6.583 | Return On Assets | Return On Equity |
The market value of OUTLOOK THERAPEUTICS INC is measured differently than its book value, which is the value of OUTLOOK that is recorded on the company's balance sheet. Investors also form their own opinion of OUTLOOK THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is OUTLOOK THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OUTLOOK THERAPEUTICS's market value can be influenced by many factors that don't directly affect OUTLOOK THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between OUTLOOK THERAPEUTICS's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding OUTLOOK THERAPEUTICS should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, OUTLOOK THERAPEUTICS's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
OUTLOOK THERAPEUTICS 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to OUTLOOK THERAPEUTICS's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of OUTLOOK THERAPEUTICS.
| 12/05/2025 |
| 03/05/2026 |
If you would invest 0.00 in OUTLOOK THERAPEUTICS on December 5, 2025 and sell it all today you would earn a total of 0.00 from holding OUTLOOK THERAPEUTICS INC or generate 0.0% return on investment in OUTLOOK THERAPEUTICS over 90 days. OUTLOOK THERAPEUTICS is related to or competes with Spruce Biosciences, NRX Pharmaceuticals, Cue Biopharma, Werewolf Therapeutics, IO Biotech, OS Therapies, and Coeptis Therapeutics. Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing m... More
OUTLOOK THERAPEUTICS Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure OUTLOOK THERAPEUTICS's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess OUTLOOK THERAPEUTICS INC upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 72.05 | |||
| Value At Risk | (14.29) | |||
| Potential Upside | 11.32 |
OUTLOOK THERAPEUTICS Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for OUTLOOK THERAPEUTICS's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as OUTLOOK THERAPEUTICS's standard deviation. In reality, there are many statistical measures that can use OUTLOOK THERAPEUTICS historical prices to predict the future OUTLOOK THERAPEUTICS's volatility.| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (1.37) | |||
| Total Risk Alpha | (1.83) | |||
| Treynor Ratio | 2.39 |
OUTLOOK THERAPEUTICS March 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.1) | |||
| Market Risk Adjusted Performance | 2.4 | |||
| Mean Deviation | 5.52 | |||
| Coefficient Of Variation | (689.62) | |||
| Standard Deviation | 9.54 | |||
| Variance | 91.09 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (1.37) | |||
| Total Risk Alpha | (1.83) | |||
| Treynor Ratio | 2.39 | |||
| Maximum Drawdown | 72.05 | |||
| Value At Risk | (14.29) | |||
| Potential Upside | 11.32 | |||
| Skewness | (3.25) | |||
| Kurtosis | 18.84 |
OUTLOOK THERAPEUTICS INC Backtested Returns
OUTLOOK THERAPEUTICS INC maintains Sharpe Ratio (i.e., Efficiency) of -0.19, which implies the firm had a -0.19 % return per unit of standard deviation over the last 3 months. OUTLOOK THERAPEUTICS INC exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check OUTLOOK THERAPEUTICS's Coefficient Of Variation of (689.62), risk adjusted performance of (0.1), and Market Risk Adjusted Performance of 2.4 to confirm the risk estimate we provide. The company holds a Beta of -0.58, which implies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning OUTLOOK THERAPEUTICS are expected to decrease at a much lower rate. During the bear market, OUTLOOK THERAPEUTICS is likely to outperform the market. At this point, OUTLOOK THERAPEUTICS INC has a negative expected return of -1.87%. Please make sure to check OUTLOOK THERAPEUTICS's maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if OUTLOOK THERAPEUTICS INC performance from the past will be repeated at some future point.
Auto-correlation | 0.46 |
Average predictability
OUTLOOK THERAPEUTICS INC has average predictability. Overlapping area represents the amount of predictability between OUTLOOK THERAPEUTICS time series from 5th of December 2025 to 19th of January 2026 and 19th of January 2026 to 5th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of OUTLOOK THERAPEUTICS INC price movement. The serial correlation of 0.46 indicates that about 46.0% of current OUTLOOK THERAPEUTICS price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.46 | |
| Spearman Rank Test | 0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
OUTLOOK THERAPEUTICS technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
OUTLOOK THERAPEUTICS INC Technical Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Normalized Average True Range is used to analyze tradable apportunities for OUTLOOK THERAPEUTICS INC across different markets.
About OUTLOOK THERAPEUTICS Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of OUTLOOK THERAPEUTICS INC on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of OUTLOOK THERAPEUTICS INC based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on OUTLOOK THERAPEUTICS INC price pattern first instead of the macroeconomic environment surrounding OUTLOOK THERAPEUTICS INC. By analyzing OUTLOOK THERAPEUTICS's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of OUTLOOK THERAPEUTICS's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to OUTLOOK THERAPEUTICS specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 70.3K | 73.8K | Price To Sales Ratio | 30.01 | 28.51 |
OUTLOOK THERAPEUTICS March 5, 2026 Technical Indicators
Most technical analysis of OUTLOOK help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for OUTLOOK from various momentum indicators to cycle indicators. When you analyze OUTLOOK charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.1) | |||
| Market Risk Adjusted Performance | 2.4 | |||
| Mean Deviation | 5.52 | |||
| Coefficient Of Variation | (689.62) | |||
| Standard Deviation | 9.54 | |||
| Variance | 91.09 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (1.37) | |||
| Total Risk Alpha | (1.83) | |||
| Treynor Ratio | 2.39 | |||
| Maximum Drawdown | 72.05 | |||
| Value At Risk | (14.29) | |||
| Potential Upside | 11.32 | |||
| Skewness | (3.25) | |||
| Kurtosis | 18.84 |
OUTLOOK THERAPEUTICS March 5, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as OUTLOOK stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 52,426 | ||
| Daily Balance Of Power | 0.67 | ||
| Rate Of Daily Change | 1.05 | ||
| Day Median Price | 0.44 | ||
| Day Typical Price | 0.44 | ||
| Price Action Indicator | 0.02 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OUTLOOK THERAPEUTICS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OUTLOOK THERAPEUTICS. Anticipated expansion of OUTLOOK directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive OUTLOOK THERAPEUTICS assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (2.89) | Revenue Per Share | Quarterly Revenue Growth 6.583 | Return On Assets | Return On Equity |
The market value of OUTLOOK THERAPEUTICS INC is measured differently than its book value, which is the value of OUTLOOK that is recorded on the company's balance sheet. Investors also form their own opinion of OUTLOOK THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is OUTLOOK THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OUTLOOK THERAPEUTICS's market value can be influenced by many factors that don't directly affect OUTLOOK THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between OUTLOOK THERAPEUTICS's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding OUTLOOK THERAPEUTICS should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, OUTLOOK THERAPEUTICS's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.